Product Information
TACROLIMUS 0.03% OINTMENT is a generic product labeled by Accord Healthcare Inc., priced at $0.8073 per GM under NDC 16729042110. Its NADAC has been published 359 times since Jul 10, 2019.
FDA first approved this application on Jan 31, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/g
Manufacturer
Accord Healthcare Inc.NDC
16729042110
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
5/20/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA211688FDA Approved
1/31/2019
TE Code
AB
On Market Since
5/31/2019
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.03% OINTMENT has been published 359 times since Jul 10, 2019, and over the history we have for it it has declined 81.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8073 per GM |
|---|---|
| All-time high | $5.0197 (Aug 14, 2019) |
| All-time low | $0.7182 (Jul 17, 2024) |
| 52-week high | $0.9133 |
| 52-week low | $0.8073 |
| Median price | $1.5476 |
| Average price | $2.0094 |
| Largest weekly change | +68.5% (Feb 22, 2023) |
| Weeks tracked | 359 |
| Tracking since | Jul 10, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
-1.5%
1Y
-10.3%
3Y
-37.4%
5Y
-63.0%
All
-81.0%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.03% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by Accord Healthcare Inc., is $0.8073 per GM (NDC 16729042110), effective May 20, 2026.
How has the price of TACROLIMUS 0.03% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has declined 81.0%. It has been tracked across 359 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?
Since Jul 10, 2019, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.7182 (Jul 17, 2024) to a high of $5.0197 (Aug 14, 2019), with a median of $1.5476 per GM.
Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.03% OINTMENT, is $0.5924 per GM — about 27% below TACROLIMUS 0.03% OINTMENT.
Who manufactures TACROLIMUS 0.03% OINTMENT?
TACROLIMUS 0.03% OINTMENT (NDC 16729042110) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.